cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action

SH Francis, JL Busch, JD Corbin - Pharmacological reviews, 2010 - Elsevier
To date, studies suggest that biological signaling by nitric oxide (NO) is primarily mediated
by cGMP, which is synthesized by NO-activated guanylyl cyclases and broken down by …

The MAPK signalling pathways and colorectal cancer

JY Fang, BC Richardson - The lancet oncology, 2005 - thelancet.com
There are three major subfamilies of mitogen-activated protein kinases (MAPK): the
extracellular-signal-regulated kinases (ERK MAPK); the c-jun N-terminal kinase or stress …

[HTML][HTML] Advancements in phosphodiesterase 5 inhibitors: unveiling present and future perspectives

AK ElHady, DS El-Gamil, M Abdel-Halim, AH Abadi - Pharmaceuticals, 2023 - mdpi.com
Phosphodiesterase 5 (PDE5) inhibitors presented themselves as important players in the
nitric oxide/cGMP pathway, thus exerting a profound impact on various physiological and …

COX‐2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX‐2 inhibitor celecoxib

S Grösch, I Tegeder, E Niederberger… - The FASEB …, 2001 - Wiley Online Library
The regular use of various nonsteroidal anti‐inflammatory drugs (NSAIDs) was shown to
decrease the incidence of colorectal cancer. This effect is thought to be caused …

Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator

BM Choi, HO Pae, SI Jang, YM Kim, HT Chung - BMB reports, 2002 - koreascience.kr
Nitric oxide (NO), synthesized from L-arginine by NO synthases, is a small, lipophilic,
diffusible, highly reactive molecule with dichotomous regulatory roles in many biological …

COX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugs

E Gurpinar, WE Grizzle, GA Piazza - Frontiers in oncology, 2013 - frontiersin.org
Epidemiological and clinical studies suggest that non-steroidal anti-inflammatory drugs
(NSAIDs), including cyclooxygenase (COX)-2 selective inhibitors, reduce the risk of …

Antiproliferative Effects of S-Allylmercaptocysteine on Colon Cancer Cells When Tested Alone or in Combination with Sulindac Sulfide

H Shirin, JT Pinto, Y Kawabata, JW Soh… - Cancer …, 2001 - aacrjournals.org
Epidemiological studies link increased garlic (Allium sativum) consumption with a reduced
incidence of colon cancer in various human populations. Experimental carcinogenesis …

Induction of Apoptosis by the Garlic-Derived Compound S-Allylmercaptocysteine (SAMC) Is Associated with Microtubule Depolymerization and c-Jun NH2-Terminal …

D **ao, JT Pinto, JW Soh, A Deguchi… - Cancer …, 2003 - aacrjournals.org
Epidemiological and experimental carcinogenesis studies provide evidence that
components of garlic (Allium sativum) have anticancer activity. We recently reported that the …

Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells

GM Pitari, MD Di Guglielmo, J Park, S Schulz… - Proceedings of the …, 2001 - pnas.org
The effects of Escherichia coli heat-stable enterotoxin (ST) and uroguanylin were examined
on the proliferation of T84 and Caco2 human colon carcinoma cells that express guanylyl …

Discovery and development of antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer

Q Li, HL Sham - Expert Opinion on Therapeutic Patents, 2002 - Taylor & Francis
Antimitotic agents have generated considerable interest among cytotoxic agents due to the
tremendous success of the taxanes and the widespread use of the Vinca alkaloids in clinical …